Peer Review History
| Original SubmissionNovember 5, 2024 |
|---|
|
Dear Dr. PARK, Thank you for submitting your manuscript to PLOS ONE. After careful consideration, we feel that it has merit but does not fully meet PLOS ONE’s publication criteria as it currently stands. Therefore, we invite you to submit a revised version of the manuscript that addresses the points raised during the review process. Please submit your revised manuscript by Feb 17 2025 11:59PM. If you will need more time than this to complete your revisions, please reply to this message or contact the journal office at plosone@plos.org . When you're ready to submit your revision, log on to https://www.editorialmanager.com/pone/ and select the 'Submissions Needing Revision' folder to locate your manuscript file.
If you would like to make changes to your financial disclosure, please include your updated statement in your cover letter. Guidelines for resubmitting your figure files are available below the reviewer comments at the end of this letter. If applicable, we recommend that you deposit your laboratory protocols in protocols.io to enhance the reproducibility of your results. Protocols.io assigns your protocol its own identifier (DOI) so that it can be cited independently in the future. For instructions see: https://journals.plos.org/plosone/s/submission-guidelines#loc-laboratory-protocols . Additionally, PLOS ONE offers an option for publishing peer-reviewed Lab Protocol articles, which describe protocols hosted on protocols.io. Read more information on sharing protocols at https://plos.org/protocols?utm_medium=editorial-email&utm_source=authorletters&utm_campaign=protocols . We look forward to receiving your revised manuscript. Kind regards, Taher Hatahet, Ph.D Academic Editor PLOS ONE Journal Requirements: When submitting your revision, we need you to address these additional requirements. 1. Please ensure that your manuscript meets PLOS ONE's style requirements, including those for file naming. The PLOS ONE style templates can be found at https://journals.plos.org/plosone/s/file?id=wjVg/PLOSOne_formatting_sample_main_body.pdf and 2. PLOS ONE now requires that authors provide the original uncropped and unadjusted images underlying all blot or gel results reported in a submission’s figures or Supporting Information files. This policy and the journal’s other requirements for blot/gel reporting and figure preparation are described in detail at https://journals.plos.org/plosone/s/figures#loc-blot-and-gel-reporting-requirements and https://journals.plos.org/plosone/s/figures#loc-preparing-figures-from-image-files. When you submit your revised manuscript, please ensure that your figures adhere fully to these guidelines and provide the original underlying images for all blot or gel data reported in your submission. See the following link for instructions on providing the original image data: https://journals.plos.org/plosone/s/figures#loc-original-images-for-blots-and-gels. In your cover letter, please note whether your blot/gel image data are in Supporting Information or posted at a public data repository, provide the repository URL if relevant, and provide specific details as to which raw blot/gel images, if any, are not available. Email us at plosone@plos.org if you have any questions. 3. Please include captions for your Supporting Information files at the end of your manuscript, and update any in-text citations to match accordingly. Please see our Supporting Information guidelines for more information: http://journals.plos.org/plosone/s/supporting-information. Additional Editor Comments: Please address the comments form reviewer one and two. Regarding blot/gel data: PLOS ONE now requires that submissions reporting blots or gels include original, uncropped blot/gel image data as a supplement or in a public repository. This is in addition to complying with our image preparation guidelines described at https://journals.plos.org/plosone/s/figures#loc-blot-and-gel-reporting-requirements. These requirements apply both to the main figures and to cropped blot/gel images included in Supporting Information. [Note: HTML markup is below. Please do not edit.] Reviewers' comments: Reviewer's Responses to Questions Comments to the Author 1. Is the manuscript technically sound, and do the data support the conclusions? Reviewer #1: Yes Reviewer #2: Partly Reviewer #3: Yes ********** 2. Has the statistical analysis been performed appropriately and rigorously? -->?> Reviewer #1: Yes Reviewer #2: N/A Reviewer #3: Yes ********** 3. Have the authors made all data underlying the findings in their manuscript fully available??> The PLOS Data policy Reviewer #1: Yes Reviewer #2: Yes Reviewer #3: Yes ********** 4. Is the manuscript presented in an intelligible fashion and written in standard English??> Reviewer #1: No Reviewer #2: Yes Reviewer #3: Yes ********** Reviewer #1: Below is a structured review of the manuscript titled "Enhancement of antiphotoaging properties of Cannabis sativa stem extracts by fermentation with Lacticaseibacillus casei". Comments are categorized into major and minor points based on their criticality for improving the manuscript. Major Comments Abstract and Objectives Clarity: The abstract concisely summarizes the study but lacks specific numerical data or comparative metrics to substantiate claims (e.g., "enhanced bioactivity"). Including key results such as specific percentage improvements in antioxidant activity or reductions in MMP-1 expression would strengthen the abstract. The study's objectives in the Introduction section should explicitly mention the novelty of using Cannabis sativa stems, differentiating it from prior work focusing on other plant parts. Experimental Design: The choice of fermentation duration (72 hours) and conditions (e.g., shaking speed, temperature) for L. casei lacks justification. Why were these parameters chosen, and were any preliminary optimization experiments conducted? Control comparisons: The inclusion of ascorbic acid as a positive control is appropriate, but the authors should also compare fermented and non-fermented extracts statistically to determine the significance of fermentation specifically. Data Analysis and Representation: The manuscript does not report effect sizes or confidence intervals for the data, which are critical for assessing biological relevance, especially in translational contexts. Figures lack sufficient annotations to guide interpretation. For example, Figure 2 (Western blot) should indicate molecular weight markers and justify the specific signaling pathways selected. Biological Relevance and Clinical Translation: The in vitro model using HDFs is appropriate but limited. The discussion acknowledges this but could be improved by suggesting specific in vivo models (e.g., murine photoaging models) for future validation. The focus solely on UVB-induced damage ignores the potential broader applicability of the extracts, such as protection against UVA or environmental pollutants. Mechanistic Insights: The discussion on fermentation enhancing bioactivity (e.g., flavonoid content) is convincing but speculative. Are there any specific fermentation byproducts identified that correlate with observed effects (e.g., HPLC or LC-MS data)? Without such analysis, the mechanistic claims are incomplete. Ethical Considerations: While the manuscript states that no ethical approval was required, the use of human-derived dermal fibroblasts demands a clearer mention of the cell line's origin and adherence to ethical standards for cell line use. Minor Comments Language and Terminology: Certain phrases, such as "fermentation significantly enhanced bioactivity," are vague. Replace with specific metrics (e.g., "fermentation increased flavonoid content by X%, enhancing antioxidant activity by Y%"). Repetition in the Introduction regarding Cannabis sativa’s underexplored potential in skincare can be condensed. Figures and Tables: Table 1 should include significance levels for each comparison, not just different letter labels. Use asterisks or p-values for clarity. Figures should have high resolution in the final submission to avoid interpretive issues during review. Citations and Literature Integration: Several references are over five years old. Consider citing recent studies on plant-based antiphotoaging agents or Cannabis sativa bioactivity. The introduction lacks a detailed comparison with other plant extracts fermented with Lacticaseibacillus spp. Addressing this would position the study better in the context of current literature. Formatting Issues: Ensure uniformity in referencing styles, particularly with et al. usage. Standardize units (e.g., μg/mL vs mg/mL) across the manuscript for consistency. Limitations Section: While some limitations are mentioned, the manuscript should specifically discuss the absence of mechanistic validations (e.g., metabolomic analyses of fermentation products) and the lack of UVA or other stressor evaluation. Supplementary Information: The supplementary data should detail the antibodies used in Western blotting, including catalog numbers and suppliers, for reproducibility. Overall Assessment The manuscript addresses a novel area of research with potential applications in natural skincare. However, it requires substantial revisions to improve clarity, depth, and rigor. Addressing the major comments will ensure the study's findings are robust and impactful, while minor comments focus on improving readability and presentation. Reviewer #2: The study investigates the antiphotoaging properties of fermented Cannabis sativa stem extracts using a human dermal fibroblast (HDF) model. While the authors emphasize the underexplored biological effects of cannabis stems, they also acknowledge prior research on cannabis leaves and flowers. Although stems and leaves differ significantly in their bioactive substance content, the claimed novelty of this study warrants careful consideration. The manuscript has several strengths, including its focus on an underutilized part of the plant and its exploration of fermentation as a means of enhancing bioactivity. However, there are several critical issues and clarifying points that should be addressed before the study can be considered for publication. Key Comments and Questions 1. In the section describing cytotoxicity determination, it is unclear whether all samples (including those with extracts) were UVB-irradiated. If so, please clarify the rationale behind this approach. Cytotoxicity assay should only evaluate one compound/extract at a time. 2. On line 155, the term "CW" appears but is not defined in the methods section. If it refers to the cannabis water extract, why is it labeled "CW" here instead of "CS," as initially described? 3. The LC control group, which is defined as the culture supernatant of Lacticaseibacillus casei, shows notable biological effects in several assays, including: - MMP-1 ELISA - ROS scavenging assays (ABTS and DPPH) - Polyphenol and flavonoid content assays - How do the authors interpret these results? Given that LC is a control group without plant extracts, its high activity raises concerns about the contributions of bacterial metabolites or medium components. 4. While the focus on stems is unique, the inclusion of cannabis leaves and flowers in the study could have provided a comparative baseline. Were these parts excluded due to practical constraints or specific research objectives? 5. The manuscript mentions UVB-induced activation of ERK, JNK, and p65 as part of the photoaging model. However, it is unclear whether these signaling changes were the sole basis for evaluating photoaging. Were additional endpoints (e.g., collagen degradation or ROS production) assessed? The activation of JNK in the UVB group appears less convincing. Could the authors provide a clearer explanation or replicate the data to confirm this pathway's role in UVB-induced photoaging? Additionally, in the FCS group, phosphorylated p65 (p-p65) appears absent, whereas the CON group shows a baseline level of p-p65. This raises questions about the reproducibility of the data or the experimental conditions. Could the authors explain why p-p65 is entirely suppressed in FCS and not in the control? 6. The study reports a nearly two-fold increase in total flavonoid content in the fermented extract (FCS) compared to the non-fermented extract (CS). While fermentation is said to enhance flavonoid production, the specific mechanism remains unexplained. Do the authors attribute this to microbial enzymatic activity, precursor transformation, or other factors? 7. On line 322, the manuscript claims that FCS reduced UVB-induced ROS levels. However, no assay directly measuring ROS levels in the presence of UVB appears in the paper. Can the authors clarify or modify this statement? 8. - The ABTS results are described as significantly different between groups, but the data show minimal variation (e.g., 88.6% for FCS vs. 89.5% for CS). This should be addressed. - In the DPPH assay, the LC control group demonstrated the highest scavenging potential, even outperforming the fermented extract (FCS). This observation contradicts the claim that fermentation enhances scavenging activity. How do the authors explain this? 9. -The LC group is defined as “L. casei culture without plant extracts”, yet it shows measurable levels of flavonoids and polyphenols. This finding is puzzling. Could this be due to assay interference, microbial metabolites, or contamination? Additional clarification is essential. Summary The study offers an intriguing approach to enhancing the antiphotoaging properties of Cannabis sativa stems through fermentation. However, several methodological inconsistencies and data interpretation issues need to be resolved. Specifically: - Clarification of UVB irradiation protocols. - Addressing discrepancies in the LC group’s activity. - Providing mechanistic insights into the effects of fermentation on flavonoid and polyphenol levels. - Revisiting claims related to ROS assays and ABTS/DPPH results. Once these issues are addressed, the study will provide a stronger contribution to the field of natural anti-photoaging agents. Reviewer #3: The authors have presented a study on the enhancement of anti-photo-aging properties of Cannabis sativa stem extracts by fermentation. The manuscript is well written, extremely detailed and easy to understand. ********** what does this mean? ). If published, this will include your full peer review and any attached files. If you choose “no”, your identity will remain anonymous but your review may still be made public. Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy Reviewer #1: No Reviewer #2: No Reviewer #3: No ********** [NOTE: If reviewer comments were submitted as an attachment file, they will be attached to this email and accessible via the submission site. Please log into your account, locate the manuscript record, and check for the action link "View Attachments". If this link does not appear, there are no attachment files.] While revising your submission, please upload your figure files to the Preflight Analysis and Conversion Engine (PACE) digital diagnostic tool, https://pacev2.apexcovantage.com/ . PACE helps ensure that figures meet PLOS requirements. To use PACE, you must first register as a user. Registration is free. Then, login and navigate to the UPLOAD tab, where you will find detailed instructions on how to use the tool. If you encounter any issues or have any questions when using PACE, please email PLOS at figures@plos.org . Please note that Supporting Information files do not need this step. |
| Revision 1 |
|
Enhancement of antiphotoaging properties of Cannabis sativa stem water extracts by fermentation with Lacticaseibacillus casei PONE-D-24-50437R1 Dear Dr. PARK, We’re pleased to inform you that your manuscript has been judged scientifically suitable for publication and will be formally accepted for publication once it meets all outstanding technical requirements. Within one week, you’ll receive an e-mail detailing the required amendments. When these have been addressed, you’ll receive a formal acceptance letter and your manuscript will be scheduled for publication. An invoice will be generated when your article is formally accepted. Please note, if your institution has a publishing partnership with PLOS and your article meets the relevant criteria, all or part of your publication costs will be covered. Please make sure your user information is up-to-date by logging into Editorial Manager at Editorial Manager® and clicking the ‘Update My Information' link at the top of the page. If you have any questions relating to publication charges, please contact our Author Billing department directly at authorbilling@plos.org. If your institution or institutions have a press office, please notify them about your upcoming paper to help maximize its impact. If they’ll be preparing press materials, please inform our press team as soon as possible -- no later than 48 hours after receiving the formal acceptance. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information, please contact onepress@plos.org. Kind regards, Taher Hatahet, Ph.D Academic Editor PLOS ONE Additional Editor Comments (optional): Dear Author thanks for addressing reveiwers comments Kind regards Reviewers' comments: |
| Formally Accepted |
|
PONE-D-24-50437R1 PLOS ONE Dear Dr. PARK, I'm pleased to inform you that your manuscript has been deemed suitable for publication in PLOS ONE. Congratulations! Your manuscript is now being handed over to our production team. At this stage, our production department will prepare your paper for publication. This includes ensuring the following: * All references, tables, and figures are properly cited * All relevant supporting information is included in the manuscript submission, * There are no issues that prevent the paper from being properly typeset You will receive further instructions from the production team, including instructions on how to review your proof when it is ready. Please keep in mind that we are working through a large volume of accepted articles, so please give us a few days to review your paper and let you know the next and final steps. Lastly, if your institution or institutions have a press office, please let them know about your upcoming paper now to help maximize its impact. If they'll be preparing press materials, please inform our press team within the next 48 hours. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information, please contact onepress@plos.org. You will receive an invoice from PLOS for your publication fee after your manuscript has reached the completed accept phase. If you receive an email requesting payment before acceptance or for any other service, this may be a phishing scheme. Learn how to identify phishing emails and protect your accounts at https://explore.plos.org/phishing. If we can help with anything else, please email us at customercare@plos.org. Thank you for submitting your work to PLOS ONE and supporting open access. Kind regards, PLOS ONE Editorial Office Staff on behalf of Dr. Taher Hatahet Academic Editor PLOS ONE |
Open letter on the publication of peer review reports
PLOS recognizes the benefits of transparency in the peer review process. Therefore, we enable the publication of all of the content of peer review and author responses alongside final, published articles. Reviewers remain anonymous, unless they choose to reveal their names.
We encourage other journals to join us in this initiative. We hope that our action inspires the community, including researchers, research funders, and research institutions, to recognize the benefits of published peer review reports for all parts of the research system.
Learn more at ASAPbio .